Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

818 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Acute coronary syndrome care across Australia and New Zealand: the SNAPSHOT ACS study.
Chew DP, French J, Briffa TG, Hammett CJ, Ellis CJ, Ranasinghe I, Aliprandi-Costa BJ, Astley CM, Turnbull FM, Lefkovits J, Redfern J, Carr B, Gamble GD, Lintern KJ, Howell TE, Parker H, Tavella R, Bloomer SG, Hyun KK, Brieger DB. Chew DP, et al. Among authors: parker h. Med J Aust. 2013 Aug 5;199(3):185-91. doi: 10.5694/mja12.11854. Med J Aust. 2013. PMID: 23909541
Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial).
Lincoff AM, Bittl JA, Kleiman NS, Sarembock IJ, Jackman JD, Mehta S, Tannenbaum MA, Niederman AL, Bachinsky WB, Tift-Mann J 3rd, Parker HG, Kereiakes DJ, Harrington RA, Feit F, Maierson ES, Chew DP, Topol EJ; REPLACE-1 Investigators. Lincoff AM, et al. Among authors: parker hg. Am J Cardiol. 2004 May 1;93(9):1092-6. doi: 10.1016/j.amjcard.2004.01.033. Am J Cardiol. 2004. PMID: 15110198 Clinical Trial.
Covalent inhibitors of the RAS binding domain of PI3Kα impair tumor growth driven by RAS and HER2.
Klebba JE, Roy N, Bernard SM, Grabow S, Hoffman MA, Miao H, Tamiya J, Wang J, Berry C, Esparza-Oros A, Lin R, Liu Y, Pariollaud M, Parker H, Mochalkin I, Rana S, Snead AN, Walton EJ, Wyrick TE, Aitichson E, Bedke K, Brannon JC, Chick JM, Hee K, Horning BD, Ismail M, Lamb KN, Lin W, Metzger J, Pastuszka MK, Pollock J, Sigler JJ, Tomaschko M, Tran E, Kinsella TM, Molina-Arcas M, Simon GM, Weinstein DS, Downward J, Patricelli MP. Klebba JE, et al. Among authors: parker h. bioRxiv [Preprint]. 2024 Dec 20:2024.12.17.629001. doi: 10.1101/2024.12.17.629001. bioRxiv. 2024. PMID: 39763752 Free PMC article. Preprint.
A Self-Administered Gamified Mobile Application for Secondary Prevention of Heart Disease in Patients Following a Cardiac Event (MyHeartMate): Process Evaluation from a Randomized Controlled Trial.
Gallagher R, Neubeck L, Davis A, Redfern J, Parker HM, Hyun K, Chow C, Celermajer DS, Buckley T, Schumacher T, Tofler G, Figtree G. Gallagher R, et al. Among authors: parker hm. Games Health J. 2024 Nov 25. doi: 10.1089/g4h.2024.0174. Online ahead of print. Games Health J. 2024. PMID: 39585749
Exercise Testing in Elite Athletes.
Rudofker E, Ochten NV, Edward J, Parker H, Wulff K, Suckow E, Forbes L, Cornwell WK 3rd. Rudofker E, et al. Among authors: parker h. Heart Fail Clin. 2025 Jan;21(1):15-25. doi: 10.1016/j.hfc.2024.05.001. Epub 2024 Oct 16. Heart Fail Clin. 2025. PMID: 39550077 Review.
Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify 2 clinicobiological subtypes.
Charalampopoulou S, Chapiro E, Nadeu F, Zenz T, Beà S, Martínez-Farran A, Aymerich M, Rozman M, Roos-Weil D, Bernard O, Susin SA, Parker H, Walewska R, Oakes CC, Strefford JC, Campo E, Matutes E, Duran-Ferrer M, Nguyen-Khac F, Martín-Subero JI. Charalampopoulou S, et al. Among authors: parker h. Blood Adv. 2024 Dec 24;8(24):6297-6307. doi: 10.1182/bloodadvances.2024013327. Blood Adv. 2024. PMID: 39471431 Free PMC article.
818 results